Vanguard Group
HSTO

Vanguard Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Vanguard Group’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-60,166
Closed -$42.8K – 4644
2023
Q2 		$42.8K Hold
60,166
– – ﹤0.01% 4474
2023
Q1 		$72.8K Buy
60,166
+46,528
+341% +$49.1K ﹤0.01% 4429
2022
Q4 		$11.3K Hold
13,638
– – ﹤0.01% 4507
2022
Q3 		$18K Sell
13,638
-781
-5% -$1.76K ﹤0.01% 4594
2022
Q2 		$33K Sell
14,419
-34,977
-71% -$126K ﹤0.01% 4601
2022
Q1 		$247K Hold
49,396
– – ﹤0.01% 4507
2021
Q4 		$328K Hold
49,396
– – ﹤0.01% 4495
2021
Q3 		$749K Buy
49,396
+1,260
+3% +$21.3K ﹤0.01% 4309
2021
Q2 		$1.05M Buy
48,136
+39,485
+456% +$819K ﹤0.01% 4141
2021
Q1 		$225K Buy
8,651
+2,436
+39% +$61.2K ﹤0.01% 4241
2020
Q4 		$94K Hold
6,215
– – ﹤0.01% 4147
2020
Q3 		$204K Sell
6,215
-315
-5% -$15.2K ﹤0.01% 3953
2020
Q2 		$497K Sell
6,530
-31
-0.5% -$2.6K ﹤0.01% 3767
2020
Q1 		$407K Sell
6,561
-192
-3% -$15K ﹤0.01% 3715
2019
Q4 		$540K Hold
6,753
– – ﹤0.01% 3781
2019
Q3 		$425K Sell
6,753
-2,557
-27% -$167K ﹤0.01% 3847
2019
Q2 		$485K Buy
9,310
+1,116
+14% +$194K ﹤0.01% 3834
2019
Q1 		$1.77M Buy
8,194
+5,253
+179% +$2.12M ﹤0.01% 3491
2018
Q4 		$1.02M Sell
2,941
-3,857
-57% -$3M ﹤0.01% 3560
2018
Q3 		$7.89M Buy
6,798
+2
+0% +$1.84K ﹤0.01% 3037
2018
Q2 		$5.82M Sell
6,796
-152
-2% -$126K ﹤0.01% 3156
2018
Q1 		$8.16M Sell
6,948
-10
-0.1% -$11.1K ﹤0.01% 2929
2017
Q4 		$6.43M Buy
6,958
+880
+14% +$813K ﹤0.01% 3032
2017
Q3 		$6.67M Buy
6,078
+1,044
+21% +$1.19M ﹤0.01% 3001
2017
Q2 		$5.8M Buy
5,034
+1,196
+31% +$1.46M ﹤0.01% 3035
2017
Q1 		$4.43M Buy
3,838
+1,850
+93% +$1.79M ﹤0.01% 3100
2016
Q4 		$2.1M Sell
1,988
-856
-30% -$389K ﹤0.01% 3348
2016
Q3 		$1.14M Buy
2,844
+599
+27% +$244K ﹤0.01% 3543
2016
Q2 		$925K Buy
2,245
+77
+4% +$37.7K ﹤0.01% 3627
2016
Q1 		$928K Buy
2,168
+149
+7% +$57.6K ﹤0.01% 3620
2015
Q4 		$1.16M Buy
2,019
+71
+4% +$49.7K ﹤0.01% 3572
2015
Q3 		$1.73M Buy
1,948
+322
+20% +$293K ﹤0.01% 3442
2015
Q2 		$1.68M Buy
1,626
+539
+50% +$632K ﹤0.01% 3481
2015
Q1 		$1.55M Buy
1,087
+38
+4% +$48.2K ﹤0.01% 3497
2014
Q4 		$1.47M Buy
1,049
+147
+16% +$212K ﹤0.01% 3388
2014
Q3 		$1.1M Buy
902
+278
+45% +$399K ﹤0.01% 3477
2014
Q2 		$1.14M Sell
624
-49
-7% -$65.4K ﹤0.01% 3456
2014
Q1 		$1.09M Buy
673
+287
+74% +$600K ﹤0.01% 3431
2013
Q4 		$498K Buy
386
+81
+27% +$129K ﹤0.01% 3598
2013
Q3 		$613K Buy
+305
New +$567K ﹤0.01% 3498

Other funds holding HSTO

SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return

Vanguard Group's HSTO Position: Q3 2023 in Review

Vanguard Group sold out of Histogen Inc. Common Stock (HSTO) in Q3 2023, closing a stake of 60,166 shares — an estimated $42.8K sold.

Vanguard Group first reported a position in HSTO in Q3 2013 and held it in 40 quarters. The position peaked at $8.16M in Q1 2018. 9 funds tracked by Wall St. Rank hold HSTO as of Q3 2023.

  • Vanguard Group reported no remaining Histogen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 60,166 Histogen Inc. Common Stock shares in Q3 2023, an estimated $42.8K.
  • Vanguard Group first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 40 quarters.
  • Vanguard Group's Histogen Inc. Common Stock position peaked at $8.16M in Q1 2018.
  • 9 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.